Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Bellet

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reports|May 1, 1987
Combination chemotherapy and hormonal therapy in the treatment of malignant melanomaE F McClay, M J Mastrangelo, R E Bellet, et al.
Cancer Research|November 1, 1979
Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanomaD Berd, E J Wilson, R E Bellet, et al.
International Journal of Cancer|February 20, 1992
Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trialsE F McClay, M J Mastrangelo, D Berd, et al.
Medical and Pediatric Oncology|January 1, 1978
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanomaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Cancer|October 11, 1975
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastasesM J Mastrangelo, R E Bellet, J Berkelhammer, et al.
American Journal of Ophthalmology|April 1, 1980
Primary choroidal and cutaneous melanomas occurring in a patient with the B-K mole syndrome phenotypeR E Bellet, J A Shields, D B Soll, et al.
Cancer|November 1, 1977
A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanomaJ F Laucius, A J Bodurtha, J M Mastrangelo, et al.
Cancer|May 1, 1973
A phase I study of emetine hydrochloride (NSC 33669) in solid tumorsM J Mastrangelo, T B Grage, R E Bellet, et al.
Neoplasma|January 1, 1973
Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study)R E Bellet, M J Mastrangelo, P F Engstrom, et al.
Cancer Chemotherapy Reports|April 1, 1973
Phase I study of ICRF-159 (NSC-129943) in human solid tumorsR E Bellet, M J Mastrangelo, L M Dixon, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reports|May 1, 1987
Combination chemotherapy and hormonal therapy in the treatment of malignant melanomaE F McClay, M J Mastrangelo, R E Bellet, et al.
Cancer Research|November 1, 1979
Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanomaD Berd, E J Wilson, R E Bellet, et al.
International Journal of Cancer|February 20, 1992
Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trialsE F McClay, M J Mastrangelo, D Berd, et al.
Medical and Pediatric Oncology|January 1, 1978
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanomaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Cancer|October 11, 1975
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastasesM J Mastrangelo, R E Bellet, J Berkelhammer, et al.
American Journal of Ophthalmology|April 1, 1980
Primary choroidal and cutaneous melanomas occurring in a patient with the B-K mole syndrome phenotypeR E Bellet, J A Shields, D B Soll, et al.
Cancer|November 1, 1977
A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanomaJ F Laucius, A J Bodurtha, J M Mastrangelo, et al.
Cancer|May 1, 1973
A phase I study of emetine hydrochloride (NSC 33669) in solid tumorsM J Mastrangelo, T B Grage, R E Bellet, et al.
Neoplasma|January 1, 1973
Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study)R E Bellet, M J Mastrangelo, P F Engstrom, et al.
Cancer Chemotherapy Reports|April 1, 1973
Phase I study of ICRF-159 (NSC-129943) in human solid tumorsR E Bellet, M J Mastrangelo, L M Dixon, et al.
Pageof 4